Black Mamba Venom: A Dual-Action Killer That Outpaces Antivenom
A study reveals that green mamba bites cause a unique form of paralysis called spastic paralysis, making treatment challenging as most antivenoms do not target this condition. The research highlights regional venom variations and the need for region-specific antivenom development, especially in India where snakebite deaths are high. Advances in monoclonal antibody treatments and increased research are crucial for better management of snakebite envenoming.
